OncLive.com
@onclive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ID: 43051682
http://www.onclive.com 28-05-2009 05:04:27
110,110K Tweet
46,46K Takipçi
1,1K Takip Edilen
Lenvatinib/Pembrolizumab Benefit Is Upheld in Advanced RCC, Including ICI-Pretreated and Naïve Subgroups Chung-Han Lee 李宗翰, MD/PhD Memorial Sloan Kettering Cancer Center KidneyCAN #KCRS23 #kcsm ow.ly/Vup250Pc5I3